1-4 of 4
Eloisi Caldas Lopes, PhD
Close
Sort by
Journal Articles

Harnessing the Epichaperome As a Therapeutic Approach in Multiple Myeloma

Eloisi Caldas Lopes, PhD, Tai Wang, PhD, David S Jayabalan, MSc, Tony Taldone, PhD, Jorge Monge, MD, Jorge Contreras, MD, Yip Winnie, Vicenta Trujillo, PhD, Panchal Palak, Nicholas Lombardi, Sharma Sahil, PhD, Digwal Chander, PhD, Morton Coleman, MD, Gabriela Chiosis, PhD, Ruben Niesvizky, MD, Monica L. Guzman, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4399.
https://doi.org/10.1182/blood-2019-125267
Published: 2019
Journal Articles

Daratumumab in Patients with Multiple Myeloma and Renal Impairment - Real-World Data from a Single-Center Institution

Jorge Monge, MD, Robin S. Solomon, Kari Flicker, BS, David S Jayabalan, MSc, Jin Guo, MD, Jorge Contreras, MD, Kathleen Pogonowski, RN, Natalie Agudo, RN, Danielle Guarneri, BS, CCRP, Brielle Liotta, BS, Eloisi Caldas Lopes, PhD, Roger Pearse, MD PhD, Morton Coleman, MD, Ruben Niesvizky, MD, Adriana C. Rossi, MDMSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5563.
https://doi.org/10.1182/blood-2019-127697
Published: 2019
Journal Articles

Characterization of DLBCL-Derived Exosomes and Investigation of Their Biological Properties

Sarah C. Rutherford, MD, Seema Sawh, Ashish Saxena, MD PhD, Jennifer Ishii, Maria D. Dominguez, PhD, Nyasha Chambwe, PhD, Eloisi Caldas Lopes, PhD, Xabier Agirre, PhD, Doron Betel, PhD, Rita Shaknovich, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3021.
https://doi.org/10.1182/blood.V124.21.3021.3021
Published: 2014
Journal Articles

Synergy of the Purine-Scaffold HSP90 Inhibitor, PU-H71, with Doxorubicin in Non-Hodgkin’s Lymphoma Cell Lines.

Lyuba Varticovski, MD, Mollie H. Wright, Eloisi Caldas-Lopes, PhD, Gabriela Chiosis, PhD, Ana I. Robles, PhD
Journal: Blood
Blood (2007) 110 (11): 1399.
https://doi.org/10.1182/blood.V110.11.1399.1399
Published: 2007